News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–19
Matches
19
Sources here
11
Companies here
1
Search results Stored financial headlines

Active search

19 matching headlines

Ticker or company: MRVIMain company stories
Clear
Latest

Stock Titan Deals and strategy

Maravai LifeSciences (MRVI) group reports 4.0M shares, 2.72% beneficial stake

A group including Hudson View Holdings LLC and JD Squared Holdings II LLC, along with individuals Stuart Feldman, Matthew Barkoff, and Joshua Wool, has reported a collective beneficial ownership of 4,009,250 shares, representing a 2.72% stake in Maravai LifeSciences Holdings, Inc. Class A common stock. This disclosure was made in a Schedule 13G/A filing, indicating that all voting …

Main company 🇺🇸 United States
Read at Stock Titan
Sharemaestro market context Trend signal active 52 weeks +132.7% · Next-week setup negative 43.4% MRVI stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Just inNext headlines

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

BioSpace Earnings Main company 🇺🇸 United States

Maravai LifeSciences Reports Second Quarter 2026 Financial Results

Maravai LifeSciences announced its second-quarter 2026 financial results, with total revenue increasing 9% year-over-year to $51.4 million. The company reported a net loss of $(21.6) million and Adjusted EBITDA of $8.7 million. Maravai also raised its full-year 2026 Adjusted EBITDA guidance to $33 million …

MRVI main company
Sharemaestro market context Trend signal active 52 weeks +132.7% · Next-week setup negative 43.4% MRVI stored weekly price path from 22 Aug 2025 to 14 Aug 2026
The National Law Review Regulatory and legal Main company 🇺🇸 United States

Levi & Korsinsky Notifies Maravai LifeSciences Holdings, Inc. Inv

Levi & Korsinsky has announced a class action lawsuit against Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) for alleged securities fraud between August 7, 2024, and February 24, 2025. The lawsuit claims Maravai lacked adequate internal controls, inaccurately recognized revenue, and overstated goodwill, leading to …

MRVI main company
Sharemaestro market context Trend signal active 52 weeks +132.7% · Next-week setup negative 43.4% MRVI stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingView Earnings Main company 🇺🇸 United States

Price to earnings forward of Maravai Lifesciences Holdings, Inc. Class A – FWB:MAR

This article provides the "Price to earnings forward" value for Maravai Lifesciences Holdings, Inc. Class A (FWB:MAR) on the Frankfurt Stock Exchange. It indicates no trades were made and the market was closed at the time the data was retrieved. The content includes general …

MRVI main company
Sharemaestro market context Trend signal active 52 weeks +132.7% · Next-week setup negative 43.4% MRVI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context